Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
Infiltration (HVAC)
Cancer Immunotherapy
Immunogenic cell death
Chemoimmunotherapy
DOI:
10.1126/sciadv.aaz9240
Publication Date:
2020-05-15T23:59:07Z
AUTHORS (6)
ABSTRACT
CXCR4 antagonistic nanocomplex regulates the immune process to enhance anti–PD-L1 immunotherapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (131)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....